PubMed

Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice.

Dewitt JC, Copeland CB, Strynar MJ, Luebke RW.

Environ Health Perspect. 2008 May;116(5):644-50.PMID: 18470313 [PubMed - indexed for MEDLINE]Related articlesFree article

Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice.

DeWitt JC, Copeland CB, Luebke RW.

Toxicol Sci. 2009 May;109(1):106-12. Epub 2009 Feb 23.PMID: 19240040 [PubMed - indexed for MEDLINE]Related articles

Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.

Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Möller G, Nelson BD, DePierre JW.

Int Immunopharmacol. 2002 Feb;2(2-3):389-97.PMID: 11811941 [PubMed - indexed for MEDLINE]Related articles

Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains.

Yang C, Tan YS, Harkema JR, Haslam SZ.

Reprod Toxicol. 2009 Jun;27(3-4):299-306. Epub 2008 Nov 1.PMID: 19013232 [PubMed - indexed for MEDLINE]Related articles

Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring.

White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE.

Toxicol Sci. 2007 Mar;96(1):133-44. Epub 2006 Nov 28.PMID: 17132714 [PubMed - indexed for MEDLINE]Related articlesFree article

Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures.

Wolf CJ, Fenton SE, Schmid JE, Calafat AM, Kuklenyik Z, Bryant XA, Thibodeaux J, Das KP, White SS, Lau CS, Abbott BD.

Toxicol Sci. 2007 Feb;95(2):462-73. Epub 2006 Nov 10.PMID: 17098816 [PubMed - indexed for MEDLINE]Related articlesFree article

Perfluorooctanoic acid and perfluorononanoic acid in fetal and neonatal mice following in utero exposure to 8-2 fluorotelomer alcohol.

Henderson WM, Smith MA.

Toxicol Sci. 2007 Feb;95(2):452-61. Epub 2006 Nov 8.PMID: 17093205 [PubMed - indexed for MEDLINE]Related articlesFree article

Perfluorooctanoic acid: relationship between repeated inhalation exposures and plasma PFOA concentration in the rat.

Hinderliter PM, DeLorme MP, Kennedy GL.

Toxicology. 2006 May 1;222(1-2):80-5. Epub 2006 Mar 2.PMID: 16513238 [PubMed - indexed for MEDLINE]Related articles

High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion.

Qazi MR, Bogdanska J, Butenhoff JL, Nelson BD, DePierre JW, Abedi-Valugerdi M.

Toxicology. 2009 Aug 21;262(3):207-14. Epub 2009 Jun 21.PMID: 19540903 [PubMed - indexed for MEDLINE]Related articles

Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life.

Hines EP, White SS, Stanko JP, Gibbs-Flournoy EA, Lau C, Fenton SE.

Mol Cell Endocrinol. 2009 May 25;304(1-2):97-105. Epub 2009 Mar 9.PMID: 19433254 [PubMed - indexed for MEDLINE]Related articles

Perfluorooctanoic acid-induced hepatic toxicity following 21-day oral exposure in mice.

Son HY, Kim SH, Shin HI, Bae HI, Yang JH.

Arch Toxicol. 2008 Apr;82(4):239-46. Epub 2007 Sep 14.PMID: 17874065 [PubMed - indexed for MEDLINE]Related articles

Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA).

Guruge KS, Yeung LW, Yamanaka N, Miyazaki S, Lam PK, Giesy JP, Jones PD, Yamashita N.

Toxicol Sci. 2006 Jan;89(1):93-107. Epub 2005 Oct 12.PMID: 16221955 [PubMed - indexed for MEDLINE]Related articlesFree article

Exposure to the immunosuppressant, perfluorooctanoic acid, enhances the murine IgE and airway hyperreactivity response to ovalbumin.

Fairley KJ, Purdy R, Kearns S, Anderson SE, Meade BJ.

Toxicol Sci. 2007 Jun;97(2):375-83. Epub 2007 Mar 15.PMID: 17369199 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.

Fenton SE, Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Hines EP, White SS, Lindstrom AB, Strynar MJ, Petropoulou SS.

Reprod Toxicol. 2009 Jun;27(3-4):365-72. Epub 2009 Mar 9.PMID: 19429407 [PubMed - indexed for MEDLINE]Related articles

Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice.

Johansson N, Fredriksson A, Eriksson P.

Neurotoxicology. 2008 Jan;29(1):160-9. Epub 2007 Nov 1.PMID: 18063051 [PubMed - indexed for MEDLINE]Related articles

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.

DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI.

Crit Rev Toxicol. 2009;39(1):76-94. Review.PMID: 18802816 [PubMed - indexed for MEDLINE]Related articles

Analysis of PFOA in dosed CD1 mice. Part 1. Methods development for the analysis of tissues and fluids from pregnant and lactating mice and their pups.

Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Fenton SE, Lindstrom AB, Strynar MJ.

Reprod Toxicol. 2009 Jun;27(3-4):360-4. Epub 2008 Nov 6.PMID: 19028561 [PubMed - indexed for MEDLINE]Related articles

Modeling single and repeated dose pharmacokinetics of PFOA in mice.

Lou I, Wambaugh JF, Lau C, Hanson RG, Lindstrom AB, Strynar MJ, Zehr RD, Setzer RW, Barton HA.

Toxicol Sci. 2009 Feb;107(2):331-41. Epub 2008 Nov 12.PMID: 19005225 [PubMed - indexed for MEDLINE]Related articles

[Effects of peroxisome proliferators PFOA on immune system of mice]

Yang J, Li A, Yang Q, Li X.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2006 Mar;22(2):157-60. Chinese. PMID: 16507247 [PubMed - indexed for MEDLINE]Related articles

Age effect on perfluorooctanoate (PFOA) plasma concentration in post-weaning rats following oral gavage with ammonium perfluorooctanoate (APFO).

Hinderliter PM, Han X, Kennedy GL, Butenhoff JL.

Toxicology. 2006 Aug 15;225(2-3):195-203. Epub 2006 Jun 9.PMID: 16857306 [PubMed - indexed for MEDLINE]Related articles